Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the Government-funded National Institute for Health and Care Research (NIHR), the trial ...

Using advanced computational genomics, Johns Hopkins investigators discovered how prostate cancer develops resistance to ...

Treatments for prostate cancers localised to the prostate have long been aimed at treating the whole prostate either by ...

Burley Brewton was able to count on a new advancement in targeted therapy after he was diagnosed with prostate cancer, the ...

NEW YORK (Reuters Health) - Men diagnosed with localized prostate cancer are more likely to be treated with proton beam therapy, a novel form of radiation therapy, if the technology is available ...

Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval making it the first ...

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...

Survivorship in metastatic prostate cancer is seen as chronic management, focusing on quality of life through physical and emotional management. Carotuximab combined with Erleada shows a favorable ...

For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has ...